Skip to main content

Home/ Dr. Goodyear/ Group items tagged OGF

Rss Feed Group items tagged

Nathan Goodyear

Low-dose naltrexone (LDN): Tricking the body to heal itself - 0 views

  •  
    synopsis of a previously posted article on LDN and OGF in the potential use in cancer.
Nathan Goodyear

Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor path... - 0 views

  •  
    low-dose naltrexone (NLD) is shown to inhibit growth in vivo.  This is important as it has implications in cancer therapies.  This study found a greater benefit with LDN and exogenous opioid growth factor (OGF).
1 - 5 of 5
Showing 20 items per page